JP2022522231A5 - - Google Patents
Info
- Publication number
- JP2022522231A5 JP2022522231A5 JP2021560212A JP2021560212A JP2022522231A5 JP 2022522231 A5 JP2022522231 A5 JP 2022522231A5 JP 2021560212 A JP2021560212 A JP 2021560212A JP 2021560212 A JP2021560212 A JP 2021560212A JP 2022522231 A5 JP2022522231 A5 JP 2022522231A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- bcma car
- item
- tcf1
- lef1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024106283A JP2024114973A (ja) | 2019-04-05 | 2024-07-01 | 抗ｂｃｍａ ｃａｒ ｔ細胞の製造 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962830004P | 2019-04-05 | 2019-04-05 | |
| US62/830,004 | 2019-04-05 | ||
| US201962944485P | 2019-12-06 | 2019-12-06 | |
| US62/944,485 | 2019-12-06 | ||
| PCT/US2020/026300 WO2020206061A1 (en) | 2019-04-05 | 2020-04-02 | Manufacturing anti-bcma car t cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024106283A Division JP2024114973A (ja) | 2019-04-05 | 2024-07-01 | 抗ｂｃｍａ ｃａｒ ｔ細胞の製造 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022522231A JP2022522231A (ja) | 2022-04-14 |
| JP2022522231A5 true JP2022522231A5 (https=) | 2023-04-10 |
| JP7584437B2 JP7584437B2 (ja) | 2024-11-15 |
Family
ID=72667055
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021560212A Active JP7584437B2 (ja) | 2019-04-05 | 2020-04-02 | 抗ｂｃｍａ ｃａｒ ｔ細胞の製造 |
| JP2024106283A Withdrawn JP2024114973A (ja) | 2019-04-05 | 2024-07-01 | 抗ｂｃｍａ ｃａｒ ｔ細胞の製造 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024106283A Withdrawn JP2024114973A (ja) | 2019-04-05 | 2024-07-01 | 抗ｂｃｍａ ｃａｒ ｔ細胞の製造 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220195060A1 (https=) |
| EP (1) | EP3946355A4 (https=) |
| JP (2) | JP7584437B2 (https=) |
| KR (1) | KR20220031541A (https=) |
| CN (1) | CN113766919B (https=) |
| AU (1) | AU2020254699A1 (https=) |
| MA (1) | MA55562A (https=) |
| WO (1) | WO2020206061A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018085690A1 (en) | 2016-11-04 | 2018-05-11 | Bluebird Bio, Inc. | Anti-bcma car t cell compositions |
| WO2019000223A1 (en) * | 2017-06-27 | 2019-01-03 | Nanjing Legend Biotech Co., Ltd. | ENABLERS OF IMMUNE EFFECTOR CELLS OF CHIMERIC ANTIBODIES AND METHODS OF USE THEREOF |
| CA3158133A1 (en) | 2020-04-28 | 2021-11-04 | Lyell Immunopharma, Inc. | Methods for culturing cells |
| CA3208300A1 (en) * | 2021-01-12 | 2022-07-21 | The Scripps Research Institute | Small molecules for reprograming anti-tumor immunity of t cells |
| EP4529559A1 (en) * | 2022-05-23 | 2025-04-02 | The Regents Of The University Of California | Methods for making and using therapeutic cells |
| AU2024350024A1 (en) * | 2023-09-25 | 2026-04-16 | The Cleveland Clinic Foundation | Enriched t-cell populations |
| WO2025065472A1 (zh) * | 2023-09-28 | 2025-04-03 | 毕诺济(上海)生物技术有限公司 | 一种改造后的t细胞及其应用 |
| WO2025076341A1 (en) | 2023-10-05 | 2025-04-10 | Janssen Biotech, Inc. | Improved methods in lentiviral manufacturing for production of car-t cell drug products |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5858358A (en) | 1992-04-07 | 1999-01-12 | The United States Of America As Represented By The Secretary Of The Navy | Methods for selectively stimulating proliferation of T cells |
| US6352694B1 (en) | 1994-06-03 | 2002-03-05 | Genetics Institute, Inc. | Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells |
| US6905680B2 (en) | 1988-11-23 | 2005-06-14 | Genetics Institute, Inc. | Methods of treating HIV infected subjects |
| US6534055B1 (en) | 1988-11-23 | 2003-03-18 | Genetics Institute, Inc. | Methods for selectively stimulating proliferation of T cells |
| US7175843B2 (en) | 1994-06-03 | 2007-02-13 | Genetics Institute, Llc | Methods for selectively stimulating proliferation of T cells |
| US6692964B1 (en) | 1995-05-04 | 2004-02-17 | The United States Of America As Represented By The Secretary Of The Navy | Methods for transfecting T cells |
| US7067318B2 (en) | 1995-06-07 | 2006-06-27 | The Regents Of The University Of Michigan | Methods for transfecting T cells |
| US6867041B2 (en) | 2000-02-24 | 2005-03-15 | Xcyte Therapies, Inc. | Simultaneous stimulation and concentration of cells |
| KR20030032922A (ko) | 2000-02-24 | 2003-04-26 | 싸이트 테라피스 인코포레이티드 | 세포의 동시 자극 및 농축 |
| US6797514B2 (en) | 2000-02-24 | 2004-09-28 | Xcyte Therapies, Inc. | Simultaneous stimulation and concentration of cells |
| HUE049514T2 (hu) * | 2014-04-25 | 2020-09-28 | Bluebird Bio Inc | Javított eljárások adoptív sejtterápiák kialakítására |
| SI3151672T1 (sl) | 2014-06-06 | 2021-03-31 | Bluebird Bio, Inc. | Izboljšani T-celični sestavki |
| HRP20191873T1 (hr) | 2014-12-12 | 2020-01-24 | Bluebird Bio, Inc. | Kimerni antigenski receptori |
| US20180214527A1 (en) * | 2015-03-26 | 2018-08-02 | City Of Hope | Bi-specific targeted chimeric antigen receptor t cells |
| IL302560B2 (en) * | 2015-10-13 | 2025-08-01 | Hope City | Chimeric antigen receptors containing a chlorotoxin domain |
| KR20180063320A (ko) | 2015-10-20 | 2018-06-11 | 카이트 파마 인코포레이티드 | T 세포 요법을 위한 t 세포를 제조하는 방법 |
| JP2020528885A (ja) * | 2017-07-19 | 2020-10-01 | フェイト セラピューティクス，インコーポレイテッド | 養子免疫療法における免疫細胞調節のための組成物および方法 |
-
2020
- 2020-04-02 JP JP2021560212A patent/JP7584437B2/ja active Active
- 2020-04-02 MA MA055562A patent/MA55562A/fr unknown
- 2020-04-02 AU AU2020254699A patent/AU2020254699A1/en active Pending
- 2020-04-02 WO PCT/US2020/026300 patent/WO2020206061A1/en not_active Ceased
- 2020-04-02 EP EP20784056.2A patent/EP3946355A4/en active Pending
- 2020-04-02 KR KR1020217035639A patent/KR20220031541A/ko active Pending
- 2020-04-02 CN CN202080031433.7A patent/CN113766919B/zh active Active
- 2020-04-02 US US17/601,383 patent/US20220195060A1/en active Pending
-
2024
- 2024-07-01 JP JP2024106283A patent/JP2024114973A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022522231A5 (https=) | ||
| JP7451468B2 (ja) | 非造血組織常在性γδ Ｔ細胞の増幅および該細胞の使用 | |
| US11535672B2 (en) | Combination of an anti-CD16A antibody with a cytokine | |
| US12594263B2 (en) | CBL inhibitors and compositions for expansion of immune cells | |
| EP1409650B1 (en) | Ex-vivo isolated cd25+cd4+ t cells with immunosuppressive activity and uses thereof | |
| CN104411819B (zh) | 用于过继细胞疗法的改进的细胞培养方法 | |
| CN113766919B (zh) | 制造抗bcma car t细胞 | |
| JP2013014587A (ja) | Ｔ細胞亜集団に特異的なモノクローナル抗体およびポリクローナル抗体の組成物および使用方法 | |
| RU2015138483A (ru) | Способы получения из опухоли обогащенных популяций реактивных в отношении опухоли т-клеток | |
| JP2024527559A5 (https=) | ||
| JP7467414B2 (ja) | 改良したｔ細胞治療方法 | |
| CN107002039A (zh) | 使用t细胞用于培养自然杀伤细胞的方法 | |
| US8323655B2 (en) | Identification of antigenic peptides from multiple myeloma cells | |
| JP2000509604A (ja) | サプレッサー細胞集団を生成するためのインターロイキン―１０の使用 | |
| CA3094610A1 (en) | Method for producing natural killer cells | |
| JP2022553411A5 (https=) | ||
| Koga et al. | IL10-and IL35-secreting MutuDC lines act in cooperation to inhibit memory T cell activation through LAG-3 expression | |
| Beltra et al. | Enhanced STAT5a activation rewires exhausted CD8 T cells during chronic stimulation to acquire a hybrid durable effector like state | |
| JP2022023136A5 (https=) | ||
| JPWO2004087210A1 (ja) | 抗ｃｄ５２抗体による調節性ｔ細胞分化誘導・増殖方法およびそのための医薬組成物 | |
| US20040147021A1 (en) | CD4+CD25 T cells and Tr1-like regulatory T cells | |
| JPWO2021100585A5 (https=) | ||
| Cavazzana et al. | Beyond conventional adoptive T-cell therapy | |
| EP4538366A1 (en) | Enhancing lineage stability of therapeutic regulatory t cell products | |
| Cren et al. | Rita Vicente, Julie Quentin, Anne-Laure |